MobiHealth News January 21, 2026
The investment brings the company’s total raise to nearly $700 million.
OpenEvidence, an AI-enabled medical research aggregate platform for doctors, has closed a $250 million Series D funding round, bringing its total raise to nearly $700 million over the past 12 months and doubling its valuation to $12 billion.
Thrive Capital and DST Global led the round.
The company said previous investors include Sequoia, Google Ventures, NVIDIA, Kleiner Perkins, Blackstone, Henry Kravis, Coatue, Thrive Capital, Conviction, ICONIQ, Greycroft, Breyer Capital, BOND, Craft Ventures, Goanna, Meritech, Alkeon, Mayo Clinic and others, and many of those entities also followed on in the Series D round.
WHAT IT DOES
OpenEvidence is a free medical information platform that offers an AI-enabled...
Today's Sponsors
Today's Sponsor